DRIEHAUS CAPITAL MANAGEMENT LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,897,565
-78.2%
181,324
-47.8%
0.09%
-77.5%
Q2 2023$31,645,954
+77.2%
347,376
+28.3%
0.40%
+59.4%
Q1 2023$17,854,910
+17.6%
270,693
-7.8%
0.25%
+11.1%
Q4 2022$15,179,212
-74.1%
293,545
-65.8%
0.23%
-74.5%
Q3 2022$58,610,000
+70.5%
858,131
+12.9%
0.89%
+59.2%
Q2 2022$34,374,000
+7.6%
760,149
+20.9%
0.56%
+42.1%
Q1 2022$31,941,000
+157.0%
628,645
+139.1%
0.39%
+208.7%
Q4 2021$12,430,000
+36.9%
262,897
-4.6%
0.13%
+17.6%
Q3 2021$9,082,000
-44.6%
275,552
+6.2%
0.11%
-50.2%
Q2 2021$16,394,000
+44.9%
259,393
-1.6%
0.22%
+29.9%
Q1 2021$11,313,000
-49.3%
263,641
-32.4%
0.17%
-53.6%
Q4 2020$22,305,000
+90.5%
389,951
+0.5%
0.36%
+50.0%
Q3 2020$11,707,000
-15.8%
388,037
-8.9%
0.24%
-29.0%
Q2 2020$13,906,000
+1.3%
425,791
-16.9%
0.34%
-26.4%
Q1 2020$13,729,000
-4.4%
512,470
-3.6%
0.46%
+20.2%
Q4 2019$14,355,000
+324.6%
531,664
+278.8%
0.38%
+247.3%
Q3 2019$3,381,000140,3440.11%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders